Vimarsana
Biggest News Aggregation in the World

Page 15 - Use Authorization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Authorization Today - Breaking & Trending Today

Investegate |LumiraDx Inc Announcements | LumiraDx Inc: LumiraDx Reports Fourth Quarter and Full Year 2022 Results - Vimarsana News

Investegate |LumiraDx Inc Announcements | LumiraDx Inc: LumiraDx Reports Fourth Quarter and Full Year 2022 Results

Investegate announcements from LumiraDx Inc, LumiraDx Reports Fourth Quarter and Full Year 2022 Results

United States: Status of FDA COVID-19-related guidance documents in the 'post-COVID' era - Vimarsana News

United States: Status of FDA COVID-19-related guidance documents in the 'post-COVID' era

On March 13, 2023, FDA issued a notice regarding guidance documents related to the COVID-19 pandemic, including which of the guidance documents will…

DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay - Vimarsana News

DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay

The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.

Source: 360dx.com
The End of an Era: FDA Announces Disposition Plans for COVID-19 Related Guidance Documents | Wiley Rein LLP - Vimarsana News

The End of an Era: FDA Announces Disposition Plans for COVID-19 Related Guidance Documents | Wiley Rein LLP

The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of...

The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies | Goodwin - Vimarsana News

The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies | Goodwin

Since the beginning of the COVID-19 pandemic, the US Food and Drug Administration (FDA or the Agency) has issued more than 80 guidance documents describing flexibilities that would be...